Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Bella, and I will be your conference operator today.
Seres Therapeutics Inc. (MCRB)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,021,957 | $966,874 | -43% | 0% |
| 2. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 433,900 | $410,511 | +622% | 0% |
| 3. | Lion Point Didric Cederholm | 340,761 | $322,394 | 0.71% | |
| 4. | Tang Capital Management Kevin C. Tang | 200,000 | $189,220 | -92% | 0.01% |
| 5. | 190,300 | $180,043 | +93% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 5,825,495 | Large Shareholder | 5,825,495 | 2022-07-05 | Filing | |
| $3.15 | 2,912,748 | Large Shareholder | 5,875,711 | 2022-07-05 | Filing | |
| $2.25 | 4,444,444 | Large Shareholder, Director | 4,444,444 | 2019-06-18 | Filing | |
| $2.25 | 4,444,444 | Large Shareholder, Director | 4,444,444 | 2019-06-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.69 | 4,334 | 30,423 | 2024-10-28 | Filing | ||
| $0.69 | 3,984 | 75,885 | 2024-10-28 | Filing | ||
| $0.69 | 4,259 | 133,414 | 2024-10-28 | Filing | ||
| $0.69 | 8,748 | 165,082 | 2024-10-28 | Filing | ||
| $0.69 | 2,983 | 88,483 | 2024-10-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,117,045 | $32,434,165 | 2.44% | |
| 2. | 19,388,580 | $27,144,012 | 0% | |
| 3. | 7,339,454 | $10,275,237 | 0% | |
| 4. | 6,005,307 | $8,407,429 | 0% | |
| 5. | 2,362,449 | $3,307,429 | 0% |
News See All
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Alex, and I will be your conference operator today.
11 Oversold NASDAQ Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold NASDAQ stocks to buy right now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, good morning. My name is Abby, and will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Seres Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today.
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2022 Earnings Call Transcript
Operator: Thank you for holding, and welcome everyone, to the Seres Therapeutics Fourth Quarter 2022 Conference Call. . Thank you. I will now turn the call over to Dr.
Cathie Wood's Top 15 Small-Cap Stock Picks
In this article, we discuss Cathie Wood’s top 15 small-cap stock picks.
Billionaire Hedge Funds
